| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | 1 | — | 3 | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 2.12 |
—
—
—
|
| 2025 | 2.07 |
—
—
—
—
|
| 2024 | 2.05 |
—
—
—
—
|
| 2023 | 2.03 |
—
—
—
—
|
| 2022 | 2.01 |
—
—
—
—
|
| 2021 | 1.99 |
—
—
—
—
|
| 2020 | 1.97 |
—
—
—
—
|
| 2019 | 1.94 |
—
—
—
—
|
| 2018 | 1.81 |
—
—
—
—
|
| 2017 | 1.47 |
—
—
—
—
|
| 2016 | 1.39 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 398.56 | 1,844.88 | 1,676.81 | 1,755.97 |
| Receivables | 1,321.11 | 1,354.23 | 1,371.35 | 1,522.33 |
| Inventory | 1,144.09 | 1,144.84 | 1,272.78 | 1,421.30 |
| Other | 192.64 | — | — | — |
| 3,390.24 | 4,484.50 | 4,506.94 | 4,951.82 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 854.47 | 848.01 | 875.68 | 955.74 |
| ST’ Debt | — | — | — | 681.79 |
| Other | 64.57 | — | — | — |
| 2,413.77 | 2,196.53 | 2,518.49 | 2,502.58 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 2,053.62 | 2,190.02 | — | — |
—
|
| ’25 | 1,866.06 | 2,049.59 | 2,077.84 | 2,099.08 |
8,092.57
|
| ’24 | 1,883.72 | 1,948.78 | 1,983.54 | 1,929.87 |
7,745.91
|
| ’23 | 2,079.02 | 2,100.09 | 1,958.43 | 1,546.94 |
7,684.48
|
| ’22 | 2,051.90 | 2,158.72 | 2,158.29 | 1,475.27 |
7,844.17
|
| ’21 | 1,867.90 | 2,031.68 | 2,018.27 | 1,989.24 |
7,907.08
|
| ’20 | 1,655.94 | 1,499.18 | 1,748.26 | 1,780.39 |
6,683.76
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 191.00 | 236.17 | — | — |
—
|
| ’25 | 157.47 | 212.34 | 424.25 | 543.95 |
1,338.01
|
| ’24 | 146.46 | 149.18 | 353.24 | 438.95 |
1,087.83
|
| ’23 | 241.28 | 195.25 | 284.44 | 498.56 |
1,219.55
|
| ’22 | 23.68 | 178.77 | 264.63 | 279.67 |
746.75
|
| ’21 | 177.18 | 260.07 | 351.33 | 327.28 |
1,115.87
|
| ’20 | 75.86 | 271.81 | 339.25 | 417.89 |
1,104.81
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 131.19 | 188.39 | — | — |
—
|
| ’25 | 113.09 | 153.60 | 370.10 | 486.96 |
1,123.74
|
| ’24 | 718.13 | 176.36 | 408.45 | 386.20 |
1,689.15
|
| ’23 | 192.91 | 155.18 | 246.77 | 441.29 |
1,036.14
|
| ’22 | (23.52) | 129.30 | 199.48 | 230.42 |
535.67
|
| ’21 | 151.77 | 218.35 | 303.89 | 277.47 |
951.47
|
| ’20 | 36.92 | 234.46 | 297.06 | 377.88 |
946.33
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.75 | 2.30 | — | — |
—
|
| ’25 | 1.67 | 2.02 | 2.19 | 2.06 |
7.94
|
| ’24 | 4.52 | 2.04 | 2.51 | 10.38 |
19.45
|
| ’23 | 1.63 | 1.72 | 2.06 | 2.11 |
7.52
|
| ’22 | 1.56 | 2.00 | 2.00 | 1.87 |
7.42
|
| ’21 | 1.61 | 1.82 | 1.81 | 2.49 |
7.74
|
| ’20 | 1.21 | 0.86 | 1.38 | 1.25 |
4.70
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 114.49 | 127.25 | 143.97 | 143.04 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 184.05 | 160.66 | 208.26 | 222.31 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25,000 | 25,000 | 24,000 | 24,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.31 | 0.31 | 0.32 | 0.34 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,844.17 | 7,684.48 | 7,745.91 | 8,092.57 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 37.03% | 37.32% | 38.20% | 39.77% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,190.20 | 1,123.00 | 1,757.02 | 1,374.25 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.17% | 14.61% | 22.68% | 16.98% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,065.38 | 1,056.83 | 2,697.13 | 1,093.96 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 295.66 | 305.05 | 337.84 | 379.58 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 54.98 | 54.95 | 56.24 | 59.10 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 7.47 | 7.56 | 19.58 | 7.99 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.23 | 8.72 | 7.90 | 9.77 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.48) | (1.31) | 4.37 | (1.56) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.75 | 7.41 | 12.26 | 8.21 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.04 | 36.52 | 50.49 | 54.08 | ‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 142.68 | 139.85 | 137.74 | 136.94 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.08 | 20.04 | 9.57 | 24.47 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.46 | 2.76 | 3.34 | 3.30 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.50 | 4.15 | 3.72 | 3.61 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.88 | 3.12 | 3.45 | 3.51 | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.22 | 23.15 | 15.82 | 25.26 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 746.75 | 1,219.55 | 1,087.83 | 1,338.01 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (211.08) | (183.41) | 601.31 | (214.26) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 535.67 | 1,036.14 | 1,689.15 | 1,123.74 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 650.19 | 976.47 | 2,287.97 | 1,988.45 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,723.51 | 2,991.76 | 2,529.35 | 2,621.30 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,342.65 | 2,593.20 | 684.47 | 944.49 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,286.37 | 5,106.61 | 6,954.00 | 7,405.21 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.00% | 9.50% | 22.61% | 8.44% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.48% | 9.90% | 9.87% | 10.28% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.14% | 22.50% | 44.73% | 15.24% | — | — | — |
ROE
|
Dover Corporation (DOV), a resilient diversified industrial leader in pumps, refrigeration, and engineered products, offers steady appeal for investors amid volatile markets. Consensus price targets suggest a range from 14% downside to 15% upside, with the mean holding flat, backed by robust revenue growth from $6.04 billion in 2016 to $7.75 billion in 2024 (3.5% CAGR), accelerating to 4-6% annually through 2027. Share repurchases have reduced outstanding shares by 12%, boosting per-share metrics, while efficiency gains—revenue per employee at $323K and gross margins expanding to 39.8%—insulate against inflation.
The 2024 profitability explosion stole the show: net income surged 155% to $2.70 billion, EPS to $19.58, ROE to 44.7%, fueled by a strategic split into two focused entities, debt reduction (net debt down 97% to $684 million), and FCF leaping 63% to $1.69 billion. Cash flow strength supports dividends, buybacks, and a fortress balance sheet, with EV/FCF at a compressed 15.8x signaling undervaluation versus historical norms.
Post-2024 normalization projects EPS rising to $10.15 by 2027 at reasonable 25x multiples, with tailwinds from industrial recovery and spin-off synergies outweighing modest insider selling. At current levels, DOV’s cash reliability and growth trajectory position it as a compelling hold or buy-on-dips for quality-focused portfolios—explore the full analysis for deeper correlations and risks.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.